Philip Morris Bach, MD
Cardiovascular Disease (Cardiology) · Sacramento
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 12
- 1 carrier
- Office
- 1
- Since medical school
- 48 years
- Georgetown University School of Medicine, 1978
Offices
1 location · Sacramento Heart and Vascular Medical · 9 clinicians in this group
Hospitals listed: Marshall Medical Center · Sutter Amador Hospital · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plans that list them
12 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Bach’s office at (916) 830-2000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G44566 · Current
Licensed to practise in California · since 1981 · expires 2028-08-31 · Georgetown University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Sacramento Heart Ambulatory Surgery Center IncAmbulatory Surgery Center · Sacramento, CA94% owner since 2015 · accredited by AAAHCAccreditation Renewed3 inspections, 2 with deficiencies · last 2025-10-08: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiology
- American Board of Internal Medicine - Cardiovascular Disease
Hospitals they work in
4 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marshall Medical CenterPlacerville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Marshall Medical CenterPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 4 of 5 starsNo measure marked better or worse than the national rate
- Sutter Amador HospitalJackson, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Marshall Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 0 worse of 7 measures. Safety: 0 better, 4 the same, 0 worse of 4 measures. Readmissions: 1 better, 8 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0 to 1.99) · 532 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.46 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 181.35 (122.12 to 240.58) · 28 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.7 · 116 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 52 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 245 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 368 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.9 · 171 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4.3 · 1,441 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.3 (0.08 to 0.52) · 3,312 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.04 to 0.45) · 3,241 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.31 (1.98 to 6.63) · 546 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.62 (0 to 3.32) · 122 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.13 (0.47 to 3.79) · 499 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.5 (0 to 16.61) · 124 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.8 (0.64 to 8.96) · 119 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.7 (0.19 to 3.2) · 135 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.26 (0 to 1.13) · 2,770 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.8 · 40 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.56 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 242 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.9 · 263 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 9.2 · 381 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 384 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 7.1 (5 to 9.9) · 225 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 15) · 225 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5 · 43 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.8 · 150 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.8 (9.1 to 15.1) · 1,577 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.5) · 545 cases | No different | Jan 2024 – Dec 2024 |
What patients said (540 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 74% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 89% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Sutter Amador Hospital
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 0 better, 3 the same, 0 worse of 3 measures. Readmissions: 1 better, 7 the same, 1 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 180 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.6 to 1.5) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 139 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14 · 233 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 81 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 803 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,886 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,831 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.13 (0.63 to 5.63) · 209 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 25 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.59 (0.88 to 4.3) · 188 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.99 (0 to 18.96) · 26 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.23) · 65 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.81 (0 to 1.84) · 1,604 cases | No different | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.7 · 138 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 0.9 · 139 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -27.8 · 230 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.5 · 226 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8.1) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (6.9 to 14.9) · 42 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.4 · 64 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.1 to 18.6) · 146 cases | No different | Jan 2022 – Dec 2024 |
What patients said (385 patients answered, 23% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 84% |
| Doctors "always" communicated well | 82% |
| Staff "always" explained | 68% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 79% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 88% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 80% |
| Nurses "always" listened carefully | 82% |
| Nurses "always" treated them with courtesy and respect | 91% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 54% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$232,763
Medicare paid this office $232,763 for 943 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 391 | $62,277 | $158 |
| Return visit (30+ min) | 367 | $48,322 | $102 |
| Short return visit (20+ min) | 529 | $44,612 | $71 |
| New patient visit (60+ min) | 151 | $24,592 | $163 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 16 | $12,385 | $774 |
See all 18 services
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 391 | $62,277 | $158 |
| Return visit (30+ min) | 367 | $48,322 | $102 |
| Short return visit (20+ min) | 529 | $44,612 | $71 |
| New patient visit (60+ min) | 151 | $24,592 | $163 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 16 | $12,385 | $774 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 781 | $9,878 | $11 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 32 | $6,969 | $218 |
| New patient visit (45+ min) | 56 | $6,893 | $123 |
| Anticoagulant management of patient taking warfarin | 27 | $4,057 | $8 |
| Low dose ct scan of chest for lung cancer screening | 22 | $2,642 | $120 |
| Ct scan of chest without contrast | 16 | $1,431 | $89 |
| Ultrasound of heart blood flow, valves and chambers | 21 | $1,005 | $48 |
| Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days | 42 | $824 | $20 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 35 | $711 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 31 | $699 | $23 |
| Heart rhythm recording continous external ekg over more than 48 hours up to 7 days | 42 | $471 | $11 |
| Heart rhythm recording of continous external ekg over 8-15 days | 35 | $358 | $10 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 15 | $329 | $22 |
Who their Medicare patients are
943 Original Medicare patients in 2024. Average age 74 · Under 65 10% · 85 and older 13% · Women 46% · Also on Medicaid 59% · Health risk score 1.47. At or below the middle of the specialty; the typical cardiology clinician is at 1.71.
Conditions among them: High blood pressure 75% · Diabetes 42% · Coronary heart disease 42% · Atrial fibrillation 30% · Heart failure 29% · Chronic kidney disease 29% · COPD 19% · Depression 17% · Cancer 11% · Stroke 11% · Dementia 6%.
The office billed $724,515, Medicare allowed $326,513 and paid $232,763; for 3,459 services of 35 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 943 | 3,459 | 74 | 1.47 | $724,515 | $232,763 |
| 2023 | 1,067 | 3,809 | 73 | 1.42 | $793,360 | $239,637 |
| 2022 | 1,166 | 4,439 | 73 | 1.40 | $906,614 | $269,110 |
| 2021 | 1,178 | 4,609 | 73 | 1.37 | $928,786 | $277,341 |
| 2020 | 1,259 | 4,960 | 73 | 1.54 | $882,796 | $290,052 |
| 2019 | 1,388 | 4,520 | 73 | 1.56 | $909,195 | $318,943 |
| 2018 | 1,615 | 5,136 | 73 | 1.54 | $1,037,868 | $357,463 |
| 2017 | 1,648 | 5,236 | 73 | 1.45 | $1,057,755 | $402,030 |
| 2016 | 1,754 | 6,020 | 73 | 1.43 | $1,078,801 | $450,111 |
| 2015 | 1,757 | 5,797 | 73 | 1.42 | $1,088,044 | $429,105 |
| 2014 | 1,530 | 5,284 | 73 | 1.29 | $944,434 | $371,218 |
| 2013 | 1,467 | 4,958 | 73 | 1.41 | $824,820 | $326,695 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 19 services
| Return visit (30+ min) | 474 | $62,003 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 407 | $60,027 | $144 |
| Short return visit (20+ min) | 509 | $40,388 | $69 |
| New patient visit (60+ min) | 107 | $16,416 | $153 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 777 | $9,963 | $10 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 13 | $9,720 | $748 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 50 | $8,451 | $169 |
| New patient visit (45+ min) | 54 | $6,694 | $124 |
| Low dose ct scan of chest for lung cancer screening | 47 | $5,214 | $111 |
| Anticoagulant management of patient taking warfarin | 29 | $4,475 | $9 |
| Ct scan of chest without contrast | 29 | $1,834 | $63 |
| Ultrasound of heart blood flow, valves and chambers | 46 | $1,792 | $39 |
| Ct scan of heart with evaluation of blood vessel calcium | 19 | $1,461 | $77 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 51 | $997 | $20 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 49 | $909 | $19 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 14 | $592 | $42 |
| X-ray of chest, 2 views | 27 | $529 | $19 |
| Heart rhythm recording of continous external ekg over 8-15 days | 51 | $497 | $10 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 14 | $275 | $20 |
2022: 18 services
| Return visit (30+ min) | 828 | $114,354 | $93 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 400 | $59,942 | $145 |
| New patient visit (60+ min) | 171 | $23,709 | $139 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 18 | $14,623 | $770 |
| Short return visit (20+ min) | 183 | $13,251 | $66 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 924 | $11,194 | $9 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 42 | $7,629 | $177 |
| Anticoagulant management of patient taking warfarin | 40 | $6,114 | $8 |
| Low dose ct scan of chest for lung cancer screening | 35 | $3,597 | $103 |
| Ct scan of chest without contrast | 41 | $2,534 | $60 |
| New patient visit (45+ min) | 23 | $2,226 | $97 |
| Ultrasound of heart blood flow, valves and chambers | 38 | $1,738 | $45 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 55 | $1,067 | $19 |
| Ct scan of heart with evaluation of blood vessel calcium | 13 | $1,052 | $81 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 42 | $904 | $21 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 27 | $601 | $21 |
| Heart rhythm recording of continous external ekg over 8-15 days | 55 | $577 | $10 |
| X-ray of chest, 2 views | 26 | $474 | $18 |
2021: 18 services
| Return visit (30+ min) | 746 | $107,748 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 378 | $60,211 | $157 |
| New patient visit (60+ min) | 147 | $22,260 | $151 |
| Short return visit (20+ min) | 224 | $17,605 | $68 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 21 | $13,032 | $621 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 872 | $11,260 | $10 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 48 | $9,212 | $192 |
| Anticoagulant management of patient taking warfarin | 54 | $8,202 | $9 |
| Low dose ct scan of chest for lung cancer screening | 52 | $3,955 | $76 |
| New patient visit (45+ min) | 30 | $3,469 | $116 |
| Ct scan of chest without contrast | 34 | $2,486 | $73 |
| Ultrasound of heart blood flow, valves and chambers | 46 | $2,024 | $44 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 47 | $1,035 | $22 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 48 | $1,018 | $21 |
| Ct scan of heart with evaluation of blood vessel calcium | 13 | $934 | $72 |
| X-ray of chest, 2 views | 47 | $887 | $18 |
| Heart rhythm recording of continous external ekg over 8-15 days | 47 | $611 | $13 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 21 | $458 | $22 |
2020: 20 services
| Return visit (30+ min) | 852 | $101,780 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 391 | $62,629 | $157 |
| New patient visit (60+ min) | 178 | $25,826 | $145 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 40 | $25,110 | $612 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 892 | $12,846 | $11 |
| Anticoagulant management of patient taking warfarin | 49 | $11,847 | $10 |
| Low dose ct scan (ldct) for lung cancer screening | 54 | $11,092 | $205 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 52 | $9,343 | $180 |
| Short return visit (20+ min) | 97 | $5,996 | $55 |
| Ct scan of chest without contrast | 53 | $4,085 | $76 |
| New patient visit (45+ min) | 20 | $2,286 | $114 |
| Ultrasound of heart blood flow, valves and chambers | 44 | $2,045 | $46 |
| Ct scan of blood vessels of chest with contrast | 13 | $1,896 | $146 |
| Ct scan of heart with evaluation of blood vessel calcium | 21 | $1,436 | $68 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 50 | $1,114 | $22 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 19 | $1,079 | $57 |
| X-ray of chest, 2 views | 55 | $946 | $17 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 39 | $854 | $22 |
| External ekg recording for more than 48 hours up to 21 days | 13 | $299 | $23 |
| Review and interpretation of external ekg recording for more than 48 hours up to 21 days | 13 | $293 | $23 |
2019: 18 services
| Return visit (30+ min) | 1,007 | $128,431 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 418 | $68,185 | $160 |
| New patient visit (60+ min) | 173 | $26,980 | $156 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 30 | $18,505 | $617 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 991 | $15,800 | $12 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 77 | $14,198 | $182 |
| Low dose ct scan (ldct) for lung cancer screening | 55 | $11,248 | $205 |
| Short return visit (20+ min) | 128 | $8,138 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 54 | $3,794 | $68 |
| Ultrasound of heart blood flow, valves and chambers | 68 | $3,202 | $46 |
| Ct scan of chest without contrast | 38 | $3,108 | $78 |
| New patient visit (45+ min) | 21 | $2,458 | $117 |
| Ct scan of blood vessels of chest with contrast | 14 | $2,221 | $159 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 73 | $1,635 | $22 |
| Anticoagulant management of patient taking warfarin | 30 | $1,382 | $10 |
| Ct scan of heart with evaluation of blood vessel calcium | 15 | $823 | $55 |
| X-ray of chest, 2 views | 43 | $648 | $14 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 31 | $602 | $19 |
2018: 21 services
| Return visit (30+ min) | 1,087 | $140,007 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 467 | $76,890 | $159 |
| New patient visit (60+ min) | 215 | $31,860 | $148 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,167 | $20,078 | $12 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 31 | $19,517 | $630 |
| Low dose ct scan (ldct) for lung cancer screening | 63 | $12,708 | $202 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 67 | $12,368 | $182 |
| Short return visit (20+ min) | 190 | $11,292 | $51 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 74 | $4,700 | $60 |
| Ct scan of chest without contrast | 43 | $3,518 | $82 |
| Ct scan of blood vessels of chest with contrast | 20 | $3,468 | $173 |
| Ct scan of blood vessels and grafts of heart with contrast | 15 | $3,080 | $205 |
| Ultrasound of heart blood flow, valves and chambers | 57 | $2,691 | $46 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 13 | $2,650 | $204 |
| Long return visit (40+ min) | 22 | $2,535 | $115 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 65 | $1,469 | $22 |
| Ct scan of heart with evaluation of blood vessel calcium | 14 | $1,069 | $76 |
| X-ray of chest, 2 views | 65 | $896 | $14 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 12 | $572 | $48 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | $527 | $19 |
| Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 12 | $352 | $29 |
2017: 21 services
| Return visit (30+ min) | 1,030 | $145,806 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 449 | $82,559 | $181 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 62 | $38,946 | $609 |
| New patient visit (60+ min) | 188 | $28,033 | $149 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 91 | $19,443 | $214 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,020 | $17,100 | $12 |
| Short return visit (20+ min) | 255 | $16,132 | $50 |
| Low dose ct scan (ldct) for lung cancer screening | 60 | $12,764 | $213 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 78 | $5,237 | $62 |
| Ultrasound of heart blood flow, valves and chambers | 84 | $3,726 | $44 |
| Ct scan of chest without contrast | 42 | $3,687 | $86 |
| Ct scan of blood vessels and grafts of heart with contrast | 13 | $2,914 | $224 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 13 | $2,910 | $224 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 87 | $1,871 | $22 |
| New patient visit (45+ min) | 13 | $1,383 | $106 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 63 | $1,368 | $21 |
| X-ray of chest, 2 views, front and side | 88 | $1,048 | $12 |
| Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 24 | $693 | $29 |
| Ct scan head or brain without contrast | 11 | $476 | $43 |
| Programming of dual lead pacemaker system | 12 | $458 | $38 |
| X-ray of lower and sacral spine, minimum of 4 views | 13 | $295 | $23 |
2016: 24 services
| Return visit (30+ min) | 1,027 | $145,102 | $79 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 487 | $87,307 | $176 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 88 | $58,012 | $617 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 135 | $29,293 | $214 |
| New patient visit (60+ min) | 167 | $25,363 | $152 |
| Short return visit (20+ min) | 370 | $24,666 | $54 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,027 | $16,923 | $12 |
| Low dose ct scan (ldct) for lung cancer screening | 56 | $13,124 | $234 |
| New patient visit (45+ min) | 64 | $7,904 | $124 |
| Ultrasound of heart blood flow, valves and chambers | 107 | $4,992 | $46 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 75 | $4,684 | $62 |
| Ct scan of chest without contrast | 30 | $2,659 | $86 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 107 | $2,374 | $22 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 91 | $2,068 | $21 |
| Ct scan of blood vessels of chest with contrast | 14 | $1,845 | $132 |
| Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) | 61 | $1,823 | $29 |
| Long return visit (40+ min) | 15 | $1,661 | $111 |
| Programming of dual lead pacemaker system | 29 | $1,205 | $34 |
| X-ray of chest, 2 views, front and side | 85 | $1,144 | $13 |
| Ct scan head or brain without contrast | 15 | $871 | $58 |
| X-ray of lower and sacral spine, minimum of 4 views | 16 | $375 | $22 |
| X-ray of knee, 4 or more views | 13 | $330 | $18 |
| X-ray of hip, 2-3 views | 12 | $305 | $25 |
| Injection, dobutamine hydrochloride, per 250 mg | 14 | $60 | None |
2015: 25 services
| Return visit (30+ min) | 968 | $135,481 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 506 | $92,377 | $179 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 76 | $45,052 | $563 |
| Short return visit (20+ min) | 413 | $31,011 | $55 |
| New patient visit (60+ min) | 194 | $28,314 | $146 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 110 | $22,676 | $204 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,110 | $20,154 | $12 |
| Ct scan of chest without contrast | 95 | $9,649 | $95 |
| New patient visit (45+ min) | 64 | $7,780 | $122 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 67 | $4,513 | $65 |
| Ultrasound of heart blood flow, valves and chambers | 93 | $4,154 | $45 |
| Ct scan of blood vessels of chest with contrast | 16 | $2,496 | $156 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 93 | $2,004 | $22 |
| Ct scan of blood vessels of neck with contrast | 17 | $1,968 | $116 |
| Ct scan of blood vessels of head with contrast | 11 | $1,787 | $162 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 83 | $1,591 | $18 |
| Long return visit (40+ min) | 17 | $1,543 | $91 |
| X-ray of chest, 2 views, front and side | 99 | $1,343 | $13 |
| Programming of dual lead pacemaker system | 23 | $1,109 | $41 |
| Ct scan head or brain without contrast | 15 | $886 | $59 |
| Ct scan of heart with evaluation of blood vessel calcium | 11 | $463 | $42 |
| X-ray of lower and sacral spine, minimum of 4 views | 12 | $272 | $23 |
| Evaluation of implantable heart and blood vessel monitoring system | 11 | $250 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 13 | $245 | $14 |
| X-ray of ribs of one side of body, minimum of 2 views | 11 | $236 | $21 |
2014: 24 services
| Return visit (30+ min) | 869 | $118,265 | $77 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 378 | $71,520 | $181 |
| Short return visit (20+ min) | 477 | $37,526 | $55 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 49 | $27,390 | $559 |
| New patient visit (60+ min) | 166 | $25,728 | $155 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 991 | $17,981 | $12 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 68 | $15,117 | $219 |
| Ct scan of chest without contrast | 63 | $6,734 | $104 |
| Ct scan of blood vessels of chest with contrast | 19 | $4,747 | $226 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 71 | $4,692 | $65 |
| Ct scan of blood vessels of neck with contrast | 14 | $3,472 | $248 |
| Ultrasound of heart blood flow, valves and chambers | 61 | $2,787 | $45 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 11 | $2,610 | $237 |
| Ct scan of blood vessels and grafts of heart with contrast | 13 | $2,337 | $180 |
| New patient visit (45+ min) | 17 | $1,924 | $113 |
| X-ray of chest, 2 views, front and side | 94 | $1,517 | $15 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 61 | $1,332 | $21 |
| Ct scan head or brain without contrast | 15 | $1,073 | $63 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 13 | $1,045 | $36 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 52 | $1,013 | $19 |
| Programming of dual lead pacemaker system | 18 | $848 | $39 |
| X-ray of lower and sacral spine, minimum of 4 views | 14 | $395 | $28 |
| X-ray of ribs of one side of body, minimum of 2 views | 15 | $388 | $24 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $261 | $20 |
2013: 23 services
| Return visit (30+ min) | 814 | $106,090 | $76 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 402 | $62,780 | $152 |
| Short return visit (20+ min) | 554 | $42,872 | $55 |
| New patient visit (60+ min) | 197 | $30,124 | $153 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 936 | $18,119 | $13 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 65 | $12,521 | $193 |
| Ct scan of blood vessels of chest with contrast | 16 | $4,119 | $242 |
| Ct scan of chest without contrast | 30 | $4,103 | $137 |
| Ct scan of blood vessels and grafts of heart with contrast | 12 | $2,516 | $210 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 35 | $2,511 | $70 |
| Ct scan head or brain without contrast | 22 | $2,226 | $101 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 22 | $1,761 | $37 |
| Ultrasound of heart blood flow, valves and chambers | 45 | $1,610 | $36 |
| X-ray of chest, 2 views, front and side | 88 | $1,543 | $17 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $969 | $57 |
| Ct scan of heart with evaluation of blood vessel calcium | 19 | $791 | $42 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 48 | $770 | $16 |
| X-ray of lower and sacral spine, minimum of 4 views | 21 | $560 | $27 |
| Programming of dual lead pacemaker system | 13 | $540 | $34 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 12 | $390 | $24 |
| X-ray of knee, 4 or more views | 13 | $374 | $27 |
| X-ray of shoulder, minimum of 2 views | 13 | $300 | $19 |
| X-ray of ribs of one side of body, minimum of 2 views | 11 | $277 | $25 |
Medicaid work
$134,859 in 2024
Medicaid paid $134,859 for 5,781 billed services this clinician did in 2024, up to 181 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 979 | $68,794 |
| New patient visit (60+ min) | 516 | $17,129 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,513 | $13,141 |
| Return visit (30+ min) | 718 | $10,709 |
| Short return visit (20+ min) | 737 | $6,952 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 121 | $6,799 |
| New patient visit (45+ min) | 242 | $4,757 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 118 | $1,898 |
| DOPPLER ECHO COMPLETE | 115 | $1,846 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 109 | $836 |
| External electrocardiographic recording for more than 48 hours up to 7 days by continuous rhythm recording and storage; review and interpretation | 101 | $629 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording) | 110 | $502 |
| 2024 | 5,781 | 14 | 181 | $134,859 |
| 2023 | 6,430 | 14 | 198 | $87,737 |
| 2022 | 5,495 | 15 | 176 | $63,932 |
| 2021 | 5,020 | 12 | 133 | $60,434 |
| 2020 | 4,827 | 11 | 149 | $62,248 |
| 2019 | 5,039 | 11 | 155 | $82,514 |
| 2018 | 4,310 | 11 | 113 | $156,753 |
See the largest Medicaid services in earlier years
2023
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 1,094 | $41,770 |
| New patient visit (60+ min) | 498 | $9,810 |
| Return visit (30+ min) | 1,009 | $9,257 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,703 | $8,148 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 129 | $5,782 |
| Short return visit (20+ min) | 829 | $5,203 |
| New patient visit (45+ min) | 245 | $2,838 |
| DOPPLER ECHO COMPLETE | 128 | $1,662 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 128 | $1,641 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 169 | $706 |
| Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed | 305 | $444 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording) | 169 | $389 |
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 840 | $29,605 |
| Return visit (30+ min) | 1,361 | $12,123 |
| New patient visit (60+ min) | 582 | $9,479 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,529 | $6,541 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 86 | $1,860 |
| Short return visit (20+ min) | 124 | $804 |
| External mobile cardiovascular telemetry with electrocardiographic recording, concurrent computerized real time data analysis and greater than 24 hours of accessible ECG data storage (retrievable with query) with ECG triggered and patient selected events transmitted to a remote attended surveillance center for up to 30 days; technical support for connection and patient instructions for use, attended surveillance, analysis and transmission of daily and emergent data reports as prescribed by a physician or other qualified health care professional | 12 | $691 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 175 | $656 |
| Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed | 398 | $586 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 86 | $466 |
| New patient visit (45+ min) | 29 | $382 |
| DOPPLER ECHO COMPLETE | 73 | $379 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 735 | $25,383 |
| Return visit (30+ min) | 1,269 | $11,080 |
| New patient visit (60+ min) | 411 | $10,382 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,327 | $5,888 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 116 | $3,324 |
| Short return visit (20+ min) | 169 | $1,206 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 95 | $725 |
| DOPPLER ECHO COMPLETE | 95 | $719 |
| New patient visit (45+ min) | 38 | $718 |
| Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed | 599 | $670 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; review and interpretation | 83 | $211 |
| External electrocardiographic recording for more than 7 days up to 15 days by continuous rhythm recording and storage; recording (includes connection and initial recording) | 83 | $128 |
2020
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 731 | $28,571 |
| Return visit (30+ min) | 1,299 | $10,755 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,250 | $6,662 |
| New patient visit (60+ min) | 271 | $3,922 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 187 | $3,337 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 60 | $2,606 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 59 | $2,120 |
| Computed tomography, thorax, diagnostic; without contrast material | 89 | $1,892 |
| Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed | 761 | $941 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 60 | $740 |
| DOPPLER ECHO COMPLETE | 60 | $703 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 811 | $38,210 |
| Return visit (30+ min) | 1,432 | $12,441 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,394 | $8,251 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 505 | $8,151 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 131 | $6,497 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 89 | $2,861 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 131 | $1,996 |
| DOPPLER ECHO COMPLETE | 128 | $1,855 |
| New patient visit (60+ min) | 43 | $1,630 |
| Computed tomography, thorax, diagnostic; without contrast material | 55 | $508 |
| Anticoagulant management for a patient taking warfarin, must include review and interpretation of a new home, office, or lab international normalized ratio (INR) test result, patient instructions, dosage adjustment (as needed), and scheduling of additional test(s), when performed | 320 | $112 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 732 | $67,118 |
| Return visit (30+ min) | 1,400 | $30,174 |
| OFFICE/OP CONSLTJ NEW/EST PT HIGH MDM 55 MINUTES | 352 | $23,113 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, during rest and cardiovascular stress test using treadmill, bicycle exercise and/or pharmacologically induced stress, with interpretation and report; including performance of continuous electrocardiographic monitoring, with supervision by a physician or other qualified health care professional | 86 | $13,306 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 1,366 | $9,986 |
| XTRNL ECG REC<48 HRS RECORDING SCAN A/R R&I | 104 | $6,564 |
| Doppler echocardiography color flow velocity mapping (List separately in addition to codes for echocardiography) | 85 | $2,196 |
| New patient visit (60+ min) | 76 | $1,731 |
| DOPPLER ECHO COMPLETE | 83 | $1,464 |
| Computed tomography, thorax, diagnostic; without contrast material | 13 | $680 |
| Long return visit (40+ min) | 13 | $421 |
Drugs they prescribed that Part D paid
$1,334,213
Pharmacies billed $1,334,213 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,104) in 2024. At or below the middle of the specialty; the typical cardiology clinician is at 0%.
5,871 generic and 1,233 brand-name prescriptions · $1,334,213 in drug cost · 20 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Xarelto | 308 | $373,418 | $1,212 |
| Eliquis | 301 | $351,648 | $1,168 |
| Entresto | 270 | $327,968 | $1,215 |
| Repatha Sureclick | 53 | $59,587 | $1,124 |
| Jardiance | 25 | $27,652 | $1,106 |
See all 58 drugs
| Xarelto | 308 | $373,418 | $1,212 |
| Eliquis | 301 | $351,648 | $1,168 |
| Entresto | 270 | $327,968 | $1,215 |
| Repatha Sureclick | 53 | $59,587 | $1,124 |
| Jardiance | 25 | $27,652 | $1,106 |
| Brilinta | 18 | $22,345 | $1,241 |
| Praluent | 15 | $20,509 | $1,367 |
| Multaq | 11 | $19,066 | $1,733 |
| Fenofibrate | 45 | $10,489 | $233 |
| Metoprolol | 788 | $9,102 | $12 |
| Atorvastatin | 831 | $8,420 | $10 |
| Amiodarone | 261 | $6,315 | $24 |
| Ranolazine Er | 27 | $3,382 | $125 |
| Nitroglycerin | 166 | $2,833 | $17 |
| Ezetimibe | 147 | $2,783 | $19 |
| Potassium Chloride | 157 | $2,727 | $17 |
| Flecainide Acetate | 57 | $2,564 | $45 |
| Carvedilol | 268 | $2,409 | $9 |
| Diltiazem 24hr Er (Cd) | 67 | $2,178 | $33 |
| Rosuvastatin | 147 | $2,171 | $15 |
| Amlodipine Besylate | 338 | $2,167 | $6 |
| Pradaxa | 11 | $2,102 | $191 |
| Lisinopril | 273 | $1,985 | $7 |
| Furosemide | 395 | $1,887 | $5 |
| Losartan | 262 | $1,815 | $7 |
| Warfarin | 108 | $1,756 | $16 |
| Clopidogrel | 124 | $1,383 | $11 |
| Digoxin | 42 | $1,333 | $32 |
| Bumetanide | 37 | $1,234 | $33 |
| Metoprolol | 224 | $1,228 | $5 |
| Atenolol | 100 | $1,101 | $11 |
| Diltiazem 24hr Er | 27 | $1,040 | $39 |
| Nifedipine Er | 32 | $1,040 | $33 |
| Isosorbide Mononitrate Er | 107 | $956 | $9 |
| Spironolactone | 113 | $920 | $8 |
| Olmesartan Medoxomil | 25 | $908 | $36 |
| Colchicine | 11 | $816 | $74 |
| Fenofibrate | 24 | $802 | $33 |
| Valsartan | 31 | $755 | $24 |
| Nebivolol | 11 | $617 | $56 |
| Clonidine | 157 | $613 | $4 |
| Simvastatin | 68 | $593 | $9 |
| Sotalol | 18 | $586 | $33 |
| Benazepril | 38 | $544 | $14 |
| Pravastatin | 37 | $494 | $13 |
| Bisoprolol | 15 | $392 | $26 |
| Verapamil Er | 20 | $384 | $19 |
| Klor-Con 10 | 28 | $374 | $13 |
| Hydrochlorothiazide | 59 | $317 | $5 |
| Cilostazol | 26 | $277 | $11 |
| Levothyroxine | 23 | $264 | $11 |
| Enalapril Maleate | 12 | $159 | $13 |
| Hydralazine | 15 | $152 | $10 |
| Lovastatin | 12 | $116 | $10 |
| Lisinopril-Hydrochlorothiazide | 21 | $95 | $5 |
| Metformin | 12 | $75 | $6 |
| Triamterene-Hydrochlorothiazid | 11 | $48 | $4 |
| Amoxicillin | 17 | $9 | $1 |
Year by year
| 2024 | 7,104 | 879 | 0% (0) | 17% | $1,334,213 |
| 2023 | 6,810 | 817 | 0% (0) | 17% | $1,326,115 |
| 2022 | 7,274 | 854 | 0% (0) | 17% | $1,201,189 |
| 2021 | 6,669 | 805 | 0% (0) | 17% | $1,056,300 |
| 2020 | 6,728 | 836 | 0% (0) | 16% | $911,649 |
| 2019 | 7,070 | 844 | 0% (0) | 17% | $898,035 |
| 2018 | 8,744 | 882 | None | None | $871,072 |
| 2017 | 9,193 | 873 | 0% (0) | 21% | $717,655 |
| 2016 | 8,745 | 873 | None | 21% | $586,803 |
| 2015 | 7,759 | 801 | 0% (0) | 23% | $483,409 |
| 2014 | 7,344 | 772 | None | 24% | $436,314 |
| 2013 | 7,261 | 787 | None | 25% | $473,879 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 53 drugs
| Xarelto | 308 | $400,585 | $1,301 |
| Entresto | 269 | $308,021 | $1,145 |
| Eliquis | 225 | $273,275 | $1,215 |
| Repatha Sureclick | 38 | $46,095 | $1,213 |
| Brilinta | 26 | $35,933 | $1,382 |
| Praluent | 16 | $19,713 | $1,232 |
| Atorvastatin | 801 | $17,406 | $22 |
| Metoprolol | 731 | $13,765 | $19 |
| Amiodarone | 221 | $10,624 | $48 |
| Ezetimibe | 114 | $9,486 | $83 |
| Ranolazine Er | 23 | $9,340 | $406 |
| Sildenafil Citrate | 21 | $6,159 | $293 |
| Carvedilol | 284 | $4,761 | $17 |
| Nitroglycerin | 150 | $4,745 | $32 |
| Flecainide Acetate | 49 | $4,655 | $95 |
| Rosuvastatin | 138 | $4,552 | $33 |
| Potassium Chloride | 156 | $4,230 | $27 |
| Losartan | 267 | $4,209 | $16 |
| Diltiazem 24hr Er (Cd) | 82 | $4,074 | $50 |
| Lisinopril | 315 | $3,964 | $13 |
| Furosemide | 428 | $3,851 | $9 |
| Amlodipine Besylate | 312 | $3,629 | $12 |
| Fenofibrate | 49 | $2,819 | $58 |
| Clopidogrel | 144 | $2,685 | $19 |
| Metoprolol | 195 | $2,651 | $14 |
| Bumetanide | 47 | $2,409 | $51 |
| Warfarin | 87 | $2,374 | $27 |
| Isosorbide Mononitrate Er | 86 | $2,263 | $26 |
| Nifedipine Er | 31 | $2,203 | $71 |
| Valsartan | 39 | $1,710 | $44 |
| Spironolactone | 101 | $1,627 | $16 |
| Atenolol | 96 | $1,377 | $14 |
| Digoxin | 38 | $1,352 | $36 |
| Clonidine | 98 | $1,299 | $13 |
| Diltiazem 24hr Er | 35 | $1,290 | $37 |
| Metolazone | 11 | $1,185 | $108 |
| Simvastatin | 57 | $1,007 | $18 |
| Benazepril | 37 | $961 | $26 |
| Bisoprolol | 11 | $887 | $81 |
| Fenofibrate | 31 | $884 | $29 |
| Klor-Con 10 | 32 | $874 | $27 |
| Olmesartan Medoxomil | 27 | $806 | $30 |
| Pravastatin | 44 | $804 | $18 |
| Cilostazol | 25 | $710 | $28 |
| Levothyroxine | 30 | $611 | $20 |
| Verapamil Er | 18 | $482 | $27 |
| Hydrochlorothiazide | 54 | $362 | $7 |
| Losartan-Hydrochlorothiazide | 16 | $325 | $20 |
| Fenofibrate | 12 | $313 | $26 |
| Lovastatin | 12 | $303 | $25 |
| Lisinopril-Hydrochlorothiazide | 26 | $274 | $11 |
| Hydralazine | 21 | $261 | $12 |
| Amoxicillin | 11 | $10 | $1 |
2022: 62 drugs
| Xarelto | 425 | $431,387 | $1,015 |
| Entresto | 218 | $245,260 | $1,125 |
| Eliquis | 228 | $243,858 | $1,070 |
| Repatha Sureclick | 28 | $30,304 | $1,082 |
| Brilinta | 24 | $21,457 | $894 |
| Pradaxa | 11 | $15,693 | $1,427 |
| Ezetimibe | 116 | $15,307 | $132 |
| Metoprolol | 826 | $13,620 | $16 |
| Atorvastatin | 840 | $11,723 | $14 |
| Praluent | 16 | $9,072 | $567 |
| Ranolazine Er | 31 | $9,065 | $292 |
| Sildenafil Citrate | 23 | $7,577 | $329 |
| Amiodarone | 159 | $7,174 | $45 |
| Nitroglycerin | 176 | $6,519 | $37 |
| Potassium Chloride | 155 | $5,799 | $37 |
| Diltiazem 24hr Er (Cd) | 93 | $5,044 | $54 |
| Rosuvastatin | 121 | $5,004 | $41 |
| Flecainide Acetate | 47 | $4,650 | $99 |
| Carvedilol | 323 | $4,189 | $13 |
| Losartan | 256 | $3,184 | $12 |
| Lisinopril | 327 | $2,837 | $9 |
| Furosemide | 415 | $2,810 | $7 |
| Amlodipine Besylate | 377 | $2,567 | $7 |
| Clopidogrel | 138 | $2,273 | $16 |
| Warfarin | 122 | $2,182 | $18 |
| Isosorbide Mononitrate Er | 106 | $2,010 | $19 |
| Metoprolol | 210 | $1,970 | $9 |
| Bystolic | 13 | $1,922 | $148 |
| Metolazone | 26 | $1,913 | $74 |
| Valsartan | 53 | $1,847 | $35 |
| Fenofibrate | 21 | $1,822 | $87 |
| Fenofibrate | 45 | $1,683 | $37 |
| Digoxin | 47 | $1,672 | $36 |
| Diltiazem 24hr Er | 39 | $1,510 | $39 |
| Nifedipine Er | 30 | $1,460 | $49 |
| Bumetanide | 29 | $1,425 | $49 |
| Clonidine | 138 | $1,416 | $10 |
| Spironolactone | 97 | $1,186 | $12 |
| Pravastatin | 53 | $1,180 | $22 |
| Benazepril | 54 | $844 | $16 |
| Simvastatin | 55 | $804 | $15 |
| Atenolol | 93 | $803 | $9 |
| Cilostazol | 35 | $705 | $20 |
| Hydralazine | 33 | $587 | $18 |
| Diltiazem | 11 | $483 | $44 |
| Klor-Con 10 | 15 | $440 | $29 |
| Klor-Con 8 | 12 | $439 | $37 |
| Diltiazem 24hr Er (Xr) | 12 | $410 | $34 |
| Minoxidil | 19 | $352 | $19 |
| Terazosin | 11 | $352 | $32 |
| Levothyroxine | 19 | $344 | $18 |
| Losartan-Hydrochlorothiazide | 13 | $331 | $25 |
| Bisoprolol | 11 | $329 | $30 |
| Hydrochlorothiazide | 61 | $325 | $5 |
| Quinapril | 18 | $281 | $16 |
| Olmesartan Medoxomil | 11 | $250 | $23 |
| Lisinopril-Hydrochlorothiazide | 20 | $246 | $12 |
| Triamterene-Hydrochlorothiazid | 14 | $207 | $15 |
| Verapamil Er | 13 | $199 | $15 |
| Lovastatin | 14 | $178 | $13 |
| Ramipril | 12 | $176 | $15 |
| Metformin | 21 | $52 | $2 |
2021: 57 drugs
| Xarelto | 394 | $425,875 | $1,081 |
| Eliquis | 182 | $196,235 | $1,078 |
| Entresto | 154 | $169,516 | $1,101 |
| Repatha Sureclick | 33 | $24,346 | $738 |
| Multaq | 17 | $23,307 | $1,371 |
| Pradaxa | 13 | $16,136 | $1,241 |
| Metoprolol | 816 | $15,347 | $19 |
| Brilinta | 20 | $13,415 | $671 |
| Atorvastatin | 764 | $12,335 | $16 |
| Praluent | 21 | $9,749 | $464 |
| Nitroglycerin | 173 | $7,266 | $42 |
| Ezetimibe | 96 | $7,033 | $73 |
| Amiodarone | 143 | $6,991 | $49 |
| Flecainide Acetate | 46 | $6,463 | $141 |
| Potassium Chloride | 165 | $6,143 | $37 |
| Rosuvastatin | 121 | $5,859 | $48 |
| Ranolazine Er | 13 | $5,079 | $391 |
| Diltiazem 24hr Er (Cd) | 63 | $4,435 | $70 |
| Carvedilol | 275 | $3,836 | $14 |
| Fenofibrate | 72 | $3,616 | $50 |
| Furosemide | 387 | $2,715 | $7 |
| Losartan | 203 | $2,709 | $13 |
| Tadalafil | 11 | $2,640 | $240 |
| Warfarin | 137 | $2,557 | $19 |
| Digoxin | 75 | $2,471 | $33 |
| Lisinopril | 340 | $2,345 | $7 |
| Amlodipine Besylate | 270 | $2,123 | $8 |
| Clopidogrel | 115 | $2,054 | $18 |
| Valsartan | 41 | $1,850 | $45 |
| Fenofibrate | 16 | $1,599 | $100 |
| Verapamil Sr | 20 | $1,541 | $77 |
| Isosorbide Mononitrate Er | 72 | $1,471 | $20 |
| Metoprolol | 187 | $1,438 | $8 |
| Pacerone | 20 | $1,436 | $72 |
| Metolazone | 14 | $1,294 | $92 |
| Clonidine | 147 | $1,182 | $8 |
| Atenolol | 94 | $1,087 | $12 |
| Cartia Xt | 20 | $1,033 | $52 |
| Spironolactone | 71 | $989 | $14 |
| Pravastatin | 55 | $895 | $16 |
| Nifedipine Er | 18 | $813 | $45 |
| Levothyroxine | 36 | $805 | $22 |
| Cilostazol | 49 | $775 | $16 |
| Isosorbide Dinitrate | 15 | $755 | $50 |
| Hydralazine | 52 | $724 | $14 |
| Quinapril | 20 | $618 | $31 |
| Losartan-Hydrochlorothiazide | 27 | $589 | $22 |
| Gemfibrozil | 13 | $581 | $45 |
| Benazepril | 27 | $522 | $19 |
| Simvastatin | 57 | $521 | $9 |
| Doxazosin Mesylate | 12 | $425 | $35 |
| Triamterene-Hydrochlorothiazid | 24 | $373 | $16 |
| Diltiazem 24hr Er | 13 | $326 | $25 |
| Hydrochlorothiazide | 69 | $310 | $4 |
| Propranolol Hcl Er | 11 | $218 | $20 |
| Lovastatin | 14 | $192 | $14 |
| Lisinopril-Hydrochlorothiazide | 11 | $62 | $6 |
2020: 53 drugs
| Xarelto | 379 | $377,050 | $995 |
| Eliquis | 165 | $157,396 | $954 |
| Entresto | 114 | $103,431 | $907 |
| Pradaxa | 32 | $26,086 | $815 |
| Repatha Sureclick | 42 | $22,341 | $532 |
| Brilinta | 19 | $17,911 | $943 |
| Metoprolol | 799 | $16,179 | $20 |
| Atorvastatin | 775 | $13,180 | $17 |
| Vascepa | 11 | $8,316 | $756 |
| Ranolazine Er | 25 | $7,890 | $316 |
| Rosuvastatin | 124 | $7,722 | $62 |
| Potassium Chloride | 196 | $7,577 | $39 |
| Flecainide Acetate | 54 | $7,271 | $135 |
| Ezetimibe | 118 | $6,832 | $58 |
| Amiodarone | 168 | $6,729 | $40 |
| Nitroglycerin | 125 | $5,931 | $47 |
| Carvedilol | 310 | $3,122 | $10 |
| Warfarin | 141 | $2,846 | $20 |
| Losartan | 248 | $2,754 | $11 |
| Valsartan | 47 | $2,663 | $57 |
| Clopidogrel | 144 | $2,451 | $17 |
| Lisinopril | 350 | $2,408 | $7 |
| Fenofibrate | 21 | $2,180 | $104 |
| Furosemide | 368 | $2,180 | $6 |
| Amlodipine Besylate | 346 | $2,152 | $6 |
| Fenofibrate | 37 | $2,077 | $56 |
| Digoxin | 49 | $2,071 | $42 |
| Diltiazem 24hr Er (Cd) | 38 | $2,004 | $53 |
| Nifedipine Er | 32 | $1,571 | $49 |
| Pravastatin | 84 | $1,539 | $18 |
| Metoprolol | 194 | $1,467 | $8 |
| Hydralazine | 58 | $1,360 | $23 |
| Isosorbide Mononitrate Er | 63 | $1,326 | $21 |
| Losartan-Hydrochlorothiazide | 16 | $1,299 | $81 |
| Clonidine | 139 | $1,098 | $8 |
| Valsartan-Hydrochlorothiazide | 21 | $1,084 | $52 |
| Atenolol | 108 | $1,010 | $9 |
| Cartia Xt | 19 | $954 | $50 |
| Spironolactone | 66 | $931 | $14 |
| Levothyroxine | 33 | $918 | $28 |
| Cilostazol | 23 | $590 | $26 |
| Diltiazem | 11 | $517 | $47 |
| Simvastatin | 55 | $427 | $8 |
| Benazepril | 44 | $422 | $10 |
| Hydrochlorothiazide | 76 | $394 | $5 |
| Lovastatin | 17 | $361 | $21 |
| Doxazosin Mesylate | 14 | $327 | $23 |
| Quinapril | 16 | $322 | $20 |
| Terazosin | 13 | $245 | $19 |
| Triamterene-Hydrochlorothiazid | 13 | $227 | $17 |
| Enalapril Maleate | 12 | $176 | $15 |
| Metformin | 11 | $105 | $10 |
| Lisinopril-Hydrochlorothiazide | 11 | $78 | $7 |
2019: 62 drugs
| Xarelto | 380 | $340,599 | $896 |
| Eliquis | 164 | $123,959 | $756 |
| Entresto | 90 | $83,731 | $930 |
| Repatha Sureclick | 48 | $45,151 | $941 |
| Multaq | 14 | $24,498 | $1,750 |
| Pradaxa | 24 | $24,129 | $1,005 |
| Metoprolol | 774 | $19,893 | $26 |
| Praluent | 22 | $18,636 | $847 |
| Atorvastatin | 849 | $15,589 | $18 |
| Ranolazine Er | 41 | $14,170 | $346 |
| Brilinta | 18 | $13,887 | $772 |
| Rosuvastatin | 128 | $9,413 | $74 |
| Potassium Chloride | 182 | $9,290 | $51 |
| Ezetimibe | 134 | $8,904 | $66 |
| Combivent Respimat | 17 | $6,920 | $407 |
| Flecainide Acetate | 78 | $6,531 | $84 |
| Nitroglycerin | 112 | $5,803 | $52 |
| Amiodarone | 189 | $5,332 | $28 |
| Bystolic | 15 | $5,131 | $342 |
| Carvedilol | 328 | $3,734 | $11 |
| Coumadin | 14 | $3,349 | $239 |
| Valsartan | 64 | $3,230 | $50 |
| Fenofibrate | 32 | $2,982 | $93 |
| Losartan | 266 | $2,843 | $11 |
| Warfarin | 131 | $2,816 | $21 |
| Amlodipine Besylate | 303 | $2,791 | $9 |
| Lisinopril | 351 | $2,710 | $8 |
| Clopidogrel | 144 | $2,518 | $17 |
| Furosemide | 340 | $2,477 | $7 |
| Isosorbide Mononitrate Er | 102 | $2,400 | $24 |
| Digoxin | 46 | $2,242 | $49 |
| Nifedipine Er | 31 | $2,161 | $70 |
| Metoprolol | 236 | $1,987 | $8 |
| Hydralazine | 68 | $1,936 | $28 |
| Pravastatin | 69 | $1,788 | $26 |
| Diltiazem 24hr Er (Cd) | 48 | $1,417 | $30 |
| Atenolol | 119 | $1,415 | $12 |
| Spironolactone | 90 | $1,299 | $14 |
| Digox | 23 | $1,279 | $56 |
| Verapamil Sr | 12 | $1,206 | $101 |
| Levothyroxine | 45 | $1,136 | $25 |
| Clonidine | 130 | $1,120 | $9 |
| Isosorbide Dinitrate | 11 | $1,057 | $96 |
| Nitroglycerin Patch | 12 | $1,052 | $88 |
| Metolazone | 16 | $923 | $58 |
| Cartia Xt | 38 | $837 | $22 |
| Cilostazol | 28 | $790 | $28 |
| Felodipine Er | 13 | $762 | $59 |
| Amlodipine Besylate-Benazepril | 11 | $747 | $68 |
| Ramipril | 12 | $742 | $62 |
| Valsartan-Hydrochlorothiazide | 17 | $719 | $42 |
| Fenofibrate | 18 | $710 | $39 |
| Simvastatin | 84 | $619 | $7 |
| Sildenafil Citrate | 12 | $552 | $46 |
| Triamterene-Hydrochlorothiazid | 25 | $419 | $17 |
| Benazepril | 49 | $397 | $8 |
| Lovastatin | 20 | $384 | $19 |
| Hydrochlorothiazide | 66 | $341 | $5 |
| Quinapril | 12 | $265 | $22 |
| Losartan-Hydrochlorothiazide | 20 | $261 | $13 |
| Enalapril Maleate | 11 | $138 | $13 |
| Lisinopril-Hydrochlorothiazide | 14 | $134 | $10 |
2018: 73 drugs
| Xarelto | 510 | $339,443 | $666 |
| Eliquis | 120 | $75,518 | $629 |
| Repatha Sureclick | 52 | $65,117 | $1,252 |
| Entresto | 76 | $45,176 | $594 |
| Pradaxa | 48 | $34,822 | $725 |
| Ranexa | 41 | $33,868 | $826 |
| Multaq | 13 | $21,796 | $1,677 |
| Praluent | 18 | $21,257 | $1,181 |
| Metoprolol | 842 | $21,112 | $25 |
| Ezetimibe | 116 | $17,896 | $154 |
| Atorvastatin | 989 | $16,456 | $17 |
| Brilinta | 21 | $11,011 | $524 |
| Potassium Chloride | 253 | $9,342 | $37 |
| Flecainide Acetate | 104 | $7,831 | $75 |
| Rosuvastatin | 165 | $7,641 | $46 |
| Amiodarone | 246 | $5,800 | $24 |
| Nitroglycerin | 99 | $5,434 | $55 |
| Combivent Respimat | 13 | $4,901 | $377 |
| Bystolic | 27 | $4,735 | $175 |
| Clopidogrel | 224 | $3,795 | $17 |
| Warfarin | 180 | $3,689 | $20 |
| Fenofibrate | 27 | $3,292 | $122 |
| Carvedilol | 401 | $3,161 | $8 |
| Digoxin | 52 | $3,084 | $59 |
| Lisinopril | 442 | $3,063 | $7 |
| Pravastatin | 114 | $2,938 | $26 |
| Amlodipine Besylate | 416 | $2,863 | $7 |
| Diltiazem 24hr Er (La) | 20 | $2,780 | $139 |
| Losartan | 289 | $2,670 | $9 |
| Olmesartan Medoxomil | 21 | $2,628 | $125 |
| Valsartan | 60 | $2,372 | $40 |
| Isosorbide Mononitrate Er | 109 | $2,191 | $20 |
| Furosemide | 480 | $2,093 | $4 |
| Nifedipine Er | 40 | $1,850 | $46 |
| Esomeprazole Magnesium | 20 | $1,834 | $92 |
| Metoprolol | 285 | $1,609 | $6 |
| Atenolol | 169 | $1,579 | $9 |
| Cilostazol | 65 | $1,524 | $23 |
| Digox | 18 | $1,513 | $84 |
| Bumetanide | 13 | $1,390 | $107 |
| Cartia Xt | 62 | $1,318 | $21 |
| Clonidine | 208 | $1,303 | $6 |
| Hydralazine | 93 | $1,289 | $14 |
| Spironolactone | 113 | $1,225 | $11 |
| Isosorbide Dinitrate | 27 | $1,157 | $43 |
| Sildenafil | 11 | $997 | $91 |
| Nitroglycerin Patch | 21 | $992 | $47 |
| Amlodipine Besylate-Benazepril | 20 | $988 | $49 |
| Levothyroxine | 40 | $937 | $23 |
| Digitek | 16 | $842 | $53 |
| Diltiazem 24hr Er (Cd) | 24 | $812 | $34 |
| Diltiazem | 23 | $736 | $32 |
| Simvastatin | 105 | $717 | $7 |
| Dilt-Xr | 16 | $714 | $45 |
| Valsartan-Hydrochlorothiazide | 18 | $709 | $39 |
| Triamterene-Hydrochlorothiazid | 51 | $577 | $11 |
| Felodipine Er | 20 | $566 | $28 |
| Omeprazole | 16 | $560 | $35 |
| Metolazone | 11 | $532 | $48 |
| Ramipril | 14 | $529 | $38 |
| Gemfibrozil | 20 | $522 | $26 |
| Lovastatin | 20 | $504 | $25 |
| Klor-Con Sprinkle | 17 | $483 | $28 |
| Allopurinol | 14 | $387 | $28 |
| Quinapril | 14 | $348 | $25 |
| Sotalol | 15 | $333 | $22 |
| Losartan-Hydrochlorothiazide | 30 | $332 | $11 |
| Benazepril | 61 | $308 | $5 |
| Klor-Con 8 | 13 | $297 | $23 |
| Hydrochlorothiazide | 72 | $243 | $3 |
| Pantoprazole | 15 | $166 | $11 |
| Lisinopril-Hydrochlorothiazide | 18 | $124 | $7 |
| Metformin | 13 | $63 | $5 |
2017: 78 drugs
| Xarelto | 434 | $225,417 | $519 |
| Repatha Sureclick | 52 | $62,079 | $1,194 |
| Pradaxa | 96 | $49,435 | $515 |
| Eliquis | 72 | $38,789 | $539 |
| Ranexa | 36 | $27,807 | $772 |
| Entresto | 45 | $23,443 | $521 |
| Multaq | 14 | $21,768 | $1,555 |
| Metoprolol | 847 | $19,589 | $23 |
| Ezetimibe | 66 | $17,904 | $271 |
| Atorvastatin | 1,008 | $15,732 | $16 |
| Zetia | 32 | $14,038 | $439 |
| Brilinta | 29 | $13,370 | $461 |
| Praluent | 11 | $12,236 | $1,112 |
| Effient | 23 | $12,142 | $528 |
| Coreg Cr | 18 | $11,379 | $632 |
| Potassium Chloride | 317 | $9,535 | $30 |
| Rosuvastatin | 109 | $6,650 | $61 |
| Benicar | 14 | $6,070 | $434 |
| Amiodarone | 212 | $5,602 | $26 |
| Flecainide Acetate | 83 | $4,461 | $54 |
| Nitroglycerin | 75 | $4,285 | $57 |
| Pravastatin | 171 | $4,167 | $24 |
| Warfarin | 175 | $3,579 | $20 |
| Olmesartan Medoxomil | 19 | $3,366 | $177 |
| Carvedilol | 512 | $3,315 | $6 |
| Beconase Aq | 12 | $3,310 | $276 |
| Bystolic | 27 | $3,273 | $121 |
| Clopidogrel | 272 | $3,101 | $11 |
| Amlodipine Besylate | 488 | $3,000 | $6 |
| Digoxin | 44 | $2,871 | $65 |
| Diltiazem 24hr Er | 53 | $2,761 | $52 |
| Lisinopril | 474 | $2,560 | $5 |
| Coumadin | 11 | $2,552 | $232 |
| Digox | 28 | $2,326 | $83 |
| Fenofibrate | 28 | $2,117 | $76 |
| Losartan | 293 | $2,096 | $7 |
| Esomeprazole Magnesium | 19 | $2,088 | $110 |
| Furosemide | 526 | $1,933 | $4 |
| Klor-Con Sprinkle | 80 | $1,928 | $24 |
| Valsartan | 76 | $1,782 | $23 |
| Nifedipine Er | 48 | $1,769 | $37 |
| Cilostazol | 76 | $1,737 | $23 |
| Metoprolol | 350 | $1,531 | $4 |
| Isosorbide Mononitrate Er | 70 | $1,481 | $21 |
| Isosorbide Dinitrate | 29 | $1,376 | $47 |
| Atenolol | 174 | $1,274 | $7 |
| Valsartan-Hydrochlorothiazide | 38 | $1,237 | $33 |
| Metolazone | 23 | $1,165 | $51 |
| Clonidine | 183 | $1,012 | $6 |
| Dilt-Xr | 24 | $869 | $36 |
| Spironolactone | 102 | $860 | $8 |
| Levothyroxine | 36 | $854 | $24 |
| Simvastatin | 153 | $854 | $6 |
| Amlodipine Besylate-Benazepril | 14 | $770 | $55 |
| Hydralazine | 80 | $741 | $9 |
| Cartia Xt | 25 | $731 | $29 |
| Benazepril | 116 | $724 | $6 |
| Lovastatin | 22 | $611 | $28 |
| Allopurinol | 19 | $580 | $31 |
| Losartan-Hydrochlorothiazide | 43 | $540 | $13 |
| Bumetanide | 11 | $529 | $48 |
| Gemfibrozil | 33 | $511 | $15 |
| Triamterene-Hydrochlorothiazid | 52 | $509 | $10 |
| Omeprazole | 26 | $509 | $20 |
| Nitrostat | 13 | $502 | $39 |
| Doxazosin Mesylate | 24 | $498 | $21 |
| Digitek | 12 | $495 | $41 |
| Fenofibrate | 12 | $484 | $40 |
| Pantoprazole | 23 | $459 | $20 |
| Felodipine Er | 23 | $439 | $19 |
| Diltiazem | 13 | $428 | $33 |
| Hydrochlorothiazide | 90 | $345 | $4 |
| Klor-Con 8 | 13 | $343 | $26 |
| Meclizine | 24 | $301 | $13 |
| Sotalol | 15 | $287 | $19 |
| Quinapril | 12 | $145 | $12 |
| Enalapril Maleate | 14 | $132 | $9 |
| Lisinopril-Hydrochlorothiazide | 20 | $75 | $4 |
2016: 75 drugs
| Xarelto | 339 | $160,420 | $473 |
| Pradaxa | 116 | $55,855 | $482 |
| Zetia | 85 | $39,741 | $468 |
| Repatha Sureclick | 24 | $25,878 | $1,078 |
| Ranexa | 35 | $23,522 | $672 |
| Multaq | 18 | $19,779 | $1,099 |
| Metoprolol | 867 | $19,178 | $22 |
| Atorvastatin | 951 | $19,119 | $20 |
| Coreg Cr | 22 | $15,665 | $712 |
| Eliquis | 34 | $13,411 | $394 |
| Crestor | 25 | $11,956 | $478 |
| Benicar | 24 | $11,215 | $467 |
| Potassium Chloride | 301 | $9,165 | $30 |
| Vytorin | 15 | $6,175 | $412 |
| Brilinta | 16 | $6,064 | $379 |
| Nitrostat | 72 | $4,630 | $64 |
| Pravastatin | 215 | $4,501 | $21 |
| Lipitor | 11 | $4,493 | $408 |
| Spiriva | 11 | $4,384 | $399 |
| Amiodarone | 272 | $4,258 | $16 |
| Clopidogrel | 264 | $3,928 | $15 |
| Valsartan | 62 | $3,741 | $60 |
| Flecainide Acetate | 59 | $3,708 | $63 |
| Digoxin | 77 | $3,376 | $44 |
| Warfarin | 198 | $3,301 | $17 |
| Carvedilol | 546 | $3,260 | $6 |
| Amlodipine Besylate | 532 | $3,230 | $6 |
| Lisinopril | 506 | $2,881 | $6 |
| Nexium | 11 | $2,818 | $256 |
| Metolazone | 36 | $2,599 | $72 |
| Rosuvastatin | 20 | $2,509 | $125 |
| Fenofibrate | 33 | $2,369 | $72 |
| Isosorbide Dinitrate | 27 | $2,190 | $81 |
| Digox | 40 | $2,012 | $50 |
| Furosemide | 514 | $1,909 | $4 |
| Losartan | 256 | $1,817 | $7 |
| Diltiazem 24hr Er | 33 | $1,782 | $54 |
| Bystolic | 14 | $1,524 | $109 |
| Benazepril-Hydrochlorothiazide | 16 | $1,478 | $92 |
| Nitroglycerin | 24 | $1,442 | $60 |
| Spironolactone | 148 | $1,385 | $9 |
| Amlodipine Besylate-Benazepril | 23 | $1,362 | $59 |
| Clonidine | 142 | $1,349 | $10 |
| Atenolol | 182 | $1,283 | $7 |
| Metoprolol | 223 | $1,155 | $5 |
| Valsartan-Hydrochlorothiazide | 38 | $1,062 | $28 |
| Cilostazol | 31 | $986 | $32 |
| Simvastatin | 187 | $968 | $5 |
| Nifedipine Er | 16 | $949 | $59 |
| Felodipine Er | 31 | $943 | $30 |
| Isosorbide Mononitrate Er | 47 | $856 | $18 |
| Hydralazine | 43 | $854 | $20 |
| Dilt-Xr | 18 | $827 | $46 |
| Cartia Xt | 22 | $727 | $33 |
| Allopurinol | 25 | $666 | $27 |
| Levothyroxine | 28 | $588 | $21 |
| Klor-Con Sprinkle | 17 | $571 | $34 |
| Doxazosin Mesylate | 26 | $555 | $21 |
| Omeprazole | 37 | $544 | $15 |
| Lovastatin | 22 | $532 | $24 |
| Benazepril | 93 | $506 | $5 |
| Hydrochlorothiazide | 94 | $472 | $5 |
| Diltiazem 24hr Cd | 11 | $386 | $35 |
| Triamterene-Hydrochlorothiazid | 34 | $376 | $11 |
| Sotalol | 21 | $349 | $17 |
| Enalapril Maleate | 11 | $330 | $30 |
| Gemfibrozil | 25 | $315 | $13 |
| Meclizine | 16 | $274 | $17 |
| Jantoven | 11 | $267 | $24 |
| Losartan-Hydrochlorothiazide | 39 | $250 | $6 |
| Quinapril | 11 | $209 | $19 |
| Klor-Con 10 | 11 | $179 | $16 |
| Pantoprazole | 17 | $145 | $9 |
| Ramipril | 14 | $85 | $6 |
| Amoxicillin | 14 | $14 | $1 |
2015: 70 drugs
| Xarelto | 305 | $126,880 | $416 |
| Pradaxa | 143 | $60,661 | $424 |
| Zetia | 85 | $30,979 | $364 |
| Ranexa | 53 | $25,570 | $482 |
| Crestor | 44 | $21,431 | $487 |
| Multaq | 20 | $19,127 | $956 |
| Atorvastatin | 834 | $18,335 | $22 |
| Metoprolol | 689 | $15,978 | $23 |
| Coreg Cr | 19 | $9,508 | $500 |
| Benicar | 31 | $8,894 | $287 |
| Potassium Chloride | 266 | $8,284 | $31 |
| Eliquis | 20 | $6,563 | $328 |
| Valsartan | 50 | $6,295 | $126 |
| Nexium | 19 | $5,870 | $309 |
| Lipitor | 17 | $5,732 | $337 |
| Pravastatin | 168 | $4,705 | $28 |
| Clopidogrel | 272 | $4,606 | $17 |
| Amiodarone | 260 | $4,605 | $18 |
| Warfarin | 191 | $4,563 | $24 |
| Vytorin | 13 | $4,333 | $333 |
| Flecainide Acetate | 57 | $3,142 | $55 |
| Brilinta | 11 | $3,104 | $282 |
| Fenofibrate | 14 | $2,859 | $204 |
| Carvedilol | 447 | $2,730 | $6 |
| Lisinopril | 462 | $2,686 | $6 |
| Isosorbide Dinitrate | 23 | $2,659 | $116 |
| Nitrostat | 70 | $2,600 | $37 |
| Metolazone | 55 | $2,506 | $46 |
| Digoxin | 47 | $2,427 | $52 |
| Coumadin | 12 | $2,420 | $202 |
| Furosemide | 412 | $1,787 | $4 |
| Amlodipine Besylate | 347 | $1,757 | $5 |
| Diltiazem 24hr Cd | 44 | $1,743 | $40 |
| Losartan | 238 | $1,643 | $7 |
| Benazepril-Hydrochlorothiazide | 21 | $1,628 | $78 |
| Valsartan-Hydrochlorothiazide | 40 | $1,569 | $39 |
| Digox | 28 | $1,404 | $50 |
| Simvastatin | 244 | $1,364 | $6 |
| Bystolic | 12 | $1,156 | $96 |
| Metoprolol | 201 | $1,107 | $6 |
| Atenolol | 166 | $1,085 | $7 |
| Amlodipine Besylate-Benazepril | 19 | $1,070 | $56 |
| Cilostazol | 32 | $1,023 | $32 |
| Spironolactone | 144 | $911 | $6 |
| Clonidine | 156 | $904 | $6 |
| Felodipine Er | 28 | $885 | $32 |
| Nifedipine Er | 13 | $757 | $58 |
| Omeprazole | 59 | $752 | $13 |
| Captopril | 11 | $715 | $65 |
| Isosorbide Mononitrate Er | 50 | $688 | $14 |
| Levothyroxine | 31 | $677 | $22 |
| Telmisartan | 12 | $663 | $55 |
| Dilt-Xr | 20 | $603 | $30 |
| Allopurinol | 28 | $601 | $21 |
| Hydralazine | 39 | $537 | $14 |
| Hydrochlorothiazide | 101 | $500 | $5 |
| Sotalol | 34 | $487 | $14 |
| Enalapril Maleate | 11 | $471 | $43 |
| Lovastatin | 26 | $464 | $18 |
| Triamterene-Hydrochlorothiazid | 28 | $450 | $16 |
| Bisoprolol | 13 | $439 | $34 |
| Cartia Xt | 12 | $380 | $32 |
| Losartan-Hydrochlorothiazide | 46 | $364 | $8 |
| Pantoprazole | 18 | $339 | $19 |
| Benazepril | 51 | $293 | $6 |
| Nitroglycerin Patch | 11 | $262 | $24 |
| Doxazosin Mesylate | 11 | $261 | $24 |
| Tamsulosin | 16 | $243 | $15 |
| Ramipril | 15 | $166 | $11 |
| Nifedical Xl | 11 | $141 | $13 |
2014: 70 drugs
| Xarelto | 198 | $78,129 | $395 |
| Pradaxa | 157 | $58,944 | $375 |
| Zetia | 80 | $24,932 | $312 |
| Atorvastatin | 894 | $22,703 | $25 |
| Multaq | 25 | $17,189 | $688 |
| Crestor | 51 | $16,299 | $320 |
| Metoprolol | 532 | $15,906 | $30 |
| Diovan | 64 | $14,384 | $225 |
| Ranexa | 32 | $13,043 | $408 |
| Nexium | 32 | $10,436 | $326 |
| Coreg Cr | 35 | $10,336 | $295 |
| Clopidogrel | 359 | $9,964 | $28 |
| Potassium Chloride | 161 | $6,513 | $40 |
| Fenofibrate | 24 | $6,492 | $271 |
| Benicar | 38 | $6,475 | $170 |
| Valsartan | 24 | $6,467 | $269 |
| Digoxin | 94 | $4,625 | $49 |
| Amiodarone | 224 | $4,503 | $20 |
| Lipitor | 16 | $4,135 | $258 |
| Carvedilol | 377 | $3,872 | $10 |
| Eliquis | 13 | $3,622 | $279 |
| Coumadin | 23 | $3,536 | $154 |
| Warfarin | 191 | $3,327 | $17 |
| Pravastatin | 86 | $3,305 | $38 |
| Flecainide Acetate | 65 | $3,230 | $50 |
| Pacerone | 28 | $3,196 | $114 |
| Losartan | 200 | $3,154 | $16 |
| Amlodipine Besylate | 373 | $2,372 | $6 |
| Valsartan-Hydrochlorothiazide | 39 | $2,306 | $59 |
| Lisinopril | 363 | $2,261 | $6 |
| Vytorin | 11 | $2,103 | $191 |
| Amlodipine Besylate-Benazepril | 21 | $2,064 | $98 |
| Isosorbide Dinitrate | 22 | $2,015 | $92 |
| Simvastatin | 232 | $1,827 | $8 |
| Nitrostat | 67 | $1,786 | $27 |
| Furosemide | 394 | $1,590 | $4 |
| Digox | 24 | $1,432 | $60 |
| Atenolol | 171 | $1,380 | $8 |
| Diltiazem 24hr Er | 57 | $1,362 | $24 |
| Bystolic | 16 | $1,355 | $85 |
| Benazepril-Hydrochlorothiazide | 22 | $1,348 | $61 |
| Clonidine | 120 | $1,147 | $10 |
| Cilostazol | 30 | $1,124 | $37 |
| Diltiazem 24hr Cd | 29 | $1,113 | $38 |
| Metoprolol | 159 | $1,059 | $7 |
| Metolazone | 30 | $1,036 | $35 |
| Levothyroxine | 54 | $897 | $17 |
| Lovastatin | 42 | $889 | $21 |
| Sotalol | 43 | $871 | $20 |
| Felodipine Er | 20 | $865 | $43 |
| Spironolactone | 102 | $852 | $8 |
| Isosorbide Mononitrate Er | 58 | $814 | $14 |
| Ramipril | 21 | $798 | $38 |
| Omeprazole | 51 | $795 | $16 |
| Nifedical Xl | 20 | $766 | $38 |
| Losartan-Hydrochlorothiazide | 45 | $704 | $16 |
| Triamterene-Hydrochlorothiazid | 43 | $601 | $14 |
| Gemfibrozil | 27 | $460 | $17 |
| Hydrochlorothiazide | 91 | $441 | $5 |
| Nitroglycerin Patch | 15 | $438 | $29 |
| Klor-Con 10 | 18 | $405 | $23 |
| Benazepril | 59 | $382 | $6 |
| Allopurinol | 41 | $342 | $8 |
| Ranitidine | 12 | $338 | $28 |
| Cartia Xt | 11 | $306 | $28 |
| Hydralazine | 19 | $206 | $11 |
| Lisinopril-Hydrochlorothiazide | 15 | $201 | $13 |
| Quinapril | 12 | $157 | $13 |
| Ibuprofen | 13 | $74 | $6 |
| Amoxicillin | 17 | $39 | $2 |
2013: 84 drugs
| Pradaxa | 211 | $70,569 | $334 |
| Xarelto | 138 | $42,352 | $307 |
| Atorvastatin | 821 | $32,347 | $39 |
| Zetia | 96 | $25,035 | $261 |
| Clopidogrel | 435 | $21,568 | $50 |
| Metoprolol | 450 | $15,776 | $35 |
| Diovan | 81 | $15,300 | $189 |
| Crestor | 53 | $13,907 | $262 |
| Multaq | 26 | $13,156 | $506 |
| Ranexa | 19 | $9,668 | $509 |
| Coreg Cr | 35 | $9,331 | $267 |
| Potassium Chloride | 164 | $7,174 | $44 |
| Lipitor | 30 | $7,034 | $234 |
| Nexium | 19 | $5,585 | $294 |
| Isosorbide Dinitrate | 50 | $5,336 | $107 |
| Valsartan-Hydrochlorothiazide | 48 | $4,580 | $95 |
| Niaspan | 17 | $4,190 | $246 |
| Carvedilol | 344 | $4,070 | $12 |
| Pacerone | 37 | $3,813 | $103 |
| Benicar | 24 | $3,683 | $153 |
| Effient | 13 | $3,389 | $261 |
| Losartan | 171 | $3,356 | $20 |
| Amiodarone | 209 | $3,295 | $16 |
| Coumadin | 23 | $3,239 | $141 |
| Flecainide Acetate | 47 | $2,687 | $57 |
| Amlodipine Besylate | 330 | $2,631 | $8 |
| Warfarin | 135 | $2,518 | $19 |
| Fenofibrate | 14 | $2,461 | $176 |
| Lisinopril | 331 | $2,369 | $7 |
| Bystolic | 21 | $2,207 | $105 |
| Simvastatin | 235 | $2,199 | $9 |
| Vytorin | 13 | $2,003 | $154 |
| Tekturna | 14 | $1,950 | $139 |
| Metoprolol | 265 | $1,874 | $7 |
| Nitrostat | 68 | $1,852 | $27 |
| Pravastatin | 92 | $1,808 | $20 |
| Omeprazole | 61 | $1,596 | $26 |
| Exforge Hct | 11 | $1,585 | $144 |
| Furosemide | 344 | $1,520 | $4 |
| Irbesartan | 11 | $1,500 | $136 |
| Amlodipine Besylate-Benazepril | 11 | $1,429 | $130 |
| Clonidine | 126 | $1,296 | $10 |
| Diltiazem 24hr Er | 41 | $1,281 | $31 |
| Nifedipine Er | 23 | $1,280 | $56 |
| Spironolactone | 103 | $1,252 | $12 |
| Atenolol | 162 | $1,179 | $7 |
| Tekturna Hct | 11 | $1,135 | $103 |
| Cilostazol | 31 | $1,095 | $35 |
| Klor-Con 8 | 19 | $1,037 | $55 |
| Diltiazem 24hr Cd | 25 | $1,029 | $41 |
| Propranolol | 21 | $954 | $45 |
| Losartan-Hydrochlorothiazide | 31 | $952 | $31 |
| Digox | 71 | $927 | $13 |
| Isosorbide Mononitrate Er | 52 | $841 | $16 |
| Sotalol | 33 | $838 | $25 |
| Diltiazem Er | 21 | $838 | $40 |
| Lovastatin | 37 | $817 | $22 |
| Benazepril | 64 | $767 | $12 |
| Nifedical Xl | 18 | $720 | $40 |
| Hydralazine | 19 | $560 | $29 |
| Hydrochlorothiazide | 88 | $534 | $6 |
| Levothyroxine | 48 | $526 | $11 |
| Quinapril | 38 | $491 | $13 |
| Benazepril-Hydrochlorothiazide | 18 | $487 | $27 |
| Verapamil Er | 12 | $461 | $38 |
| Cartia Xt | 19 | $452 | $24 |
| Ramipril | 26 | $441 | $17 |
| Triamterene-Hctz | 29 | $427 | $15 |
| Metolazone | 25 | $390 | $16 |
| Klor-Con 10 | 16 | $380 | $24 |
| Lisinopril-Hydrochlorothiazide | 28 | $367 | $13 |
| Gemfibrozil | 18 | $366 | $20 |
| Digoxin | 50 | $363 | $7 |
| Fludrocortisone Acetate | 14 | $246 | $18 |
| Captopril | 13 | $225 | $17 |
| Klor-Con M10 | 17 | $199 | $12 |
| Metformin | 22 | $149 | $7 |
| Paroxetine | 12 | $149 | $12 |
| Allopurinol | 26 | $147 | $6 |
| Enalapril Maleate | 14 | $142 | $10 |
| Alendronate | 11 | $128 | $12 |
| Terazosin | 16 | $101 | $6 |
| Ibuprofen | 15 | $74 | $5 |
| Amoxicillin | 17 | $41 | $2 |
Money from drug and device companies
$72 in 2025
| 2025 | 1 | 1 | None | $72 |
| 2024 | 6 | 13 | None | $227 |
| 2023 | 5 | 13 | None | $245 |
| 2022 | 2 | 7 | None | $121 |
| 2021 | 6 | 9 | None | $136 |
| 2020 | 4 | 6 | None | $195 |
| 2019 | 7 | 20 | None | $458 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $72 | 1 payment
|
See the published payment
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-05-20 | Lifevest | $72 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $227
| Novartis Pharmaceuticals | Leqvio | $88 | 5 payments
|
| Pfizer | Eliquis | $47 | 3 payments
|
| Alnylam Pharmaceuticals | Onpattro | $38 | 2 payments
|
| Novo Nordisk | Wegovy | $21 | 1 payment
|
| Heartflow | Ffrct | $18 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $15 | 1 payment
|
2023: $245
| Sanofi-Aventis U.S. | Multaq | $78 | 4 payments
|
| Pfizer | Eliquis | $71 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $42 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $35 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $18 | 1 payment
|
2022: $121
| Sanofi-Aventis U.S. | Multaq | $72 | 4 payments
|
| Janssen Pharmaceuticals | Xarelto | $49 | 3 payments
|
2021: $136
| Janssen Pharmaceuticals | Xarelto | $51 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $22 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $19 | 1 payment
|
| Sanofi-Aventis U.S. | Multaq | $18 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $16 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $10 | 1 payment
|
2020: $195
| Amgen | Repatha | $100 | 1 payment
|
| Biotronik | None | $57 | 3 payments
|
| Philips Electronics North America | (7999) Src Undivided | $19 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $19 | 1 payment
|
2019: $458
| Amgen | Corlanor | $149 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $117 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $107 | 8 payments
|
| Biotronik | None | $39 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $19 | 1 payment
|
| Lundbeck | Northera | $16 | 1 payment
|
| InfoBionic | Mome Kardia | $12 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 95.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1376594267
- Licence
- CA G44566California G44566: Current · expires 2028-08-31
- Trained
- Georgetown University School of Medicine, 1978 · 48 years ago
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- CA 00G445660
- Taxonomy
- Cardiology (207RC0000X)
- Mailing address
- 500 University Ave., Sacramento, CA, 95825
- NPI first listed
- 2006-05-15
- NPI last updated
- 2011-11-15
This is when the NPI record was last certified, not a medical board exam.